核酸サンプル調製市場- 世界の産業規模、シェア、動向、機会および予測、製品別、技術別、治療分野別、用途別、エンドユーザー別、地域別、競合別、2020-2030年

核酸サンプル調製の世界市場は、2024年に26億5,000万米ドルと評価され、予測期間中にCAGR 6.45％で成長し、2030年には38億6,000万米ドルに達すると予測されています。

この市場は、様々な生物学的ソースからのDNAとRNAの効率的な抽出、精製、調製を可能にすることで、ライフサイエンスと診断産業において重要な役割を果たしています。市場成長の原動力となっているのは、分子診断の応用拡大、ゲノム研究の拡大、個別化医療への世界のシフトです。世界中の研究室がより効率的でスケーラブルなワークフローを求めているため、各社は自動化、技術革新、戦略的提携に投資し、臨床と研究の両方のニーズに対応するハイスループット・ソリューションを提供しています。

市場概要
予測期間	2026-2030
市場規模：2024年	26億5,000万米ドル
市場規模：2030年	38億6,000万米ドル
CAGR：2025年～2030年	6.45%
急成長セグメント	磁気ビーズベース技術
最大市場	北米

市場促進要因

感染症管理における核酸検査の利用の増加

主な市場課題

高度なサンプル調製技術の高コスト

主要市場動向

自動化とハイスループットシステムの統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 核酸サンプル調製市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（消耗品、システム、アクセサリ、コンポーネント）
  • 技術別（スピンカラムベース技術、磁気ビーズベース技術、その他）
  • 治療領域別（腫瘍学、感染症、人類遺伝学／集団遺伝学、その他）
  • 用途別（ゲノミクス、プロテオミクス、その他）
  • エンドユーザー別（学術調査機関、製薬・バイオテクノロジー企業、臨床・診断研究所、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の核酸サンプル調製市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の核酸サンプル調製市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の核酸サンプル調製市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の核酸サンプル調製市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの核酸サンプル調製市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の核酸サンプル調製市場：SWOT分析

第14章 競合情勢

• BGI Group
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Eppendorf SE
• BIONEER CORPORATION
• Endress+Hauser Group Services AG
• Merck KGaA
• Norgen Biotek Corp.
• Aurora Biomed Inc.
• Agilent Technologies, Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Nucleic Acid Sample Preparation Market was valued at USD 2.65 Billion in 2024 and is projected to reach USD 3.86 Billion by 2030, growing at a CAGR of 6.45% during the forecast period. This market plays a vital role in the life sciences and diagnostics industry by enabling the efficient extraction, purification, and preparation of DNA and RNA from various biological sources. Market growth is fueled by the increasing application of molecular diagnostics, the expansion of genomic research, and the global shift toward personalized medicine. As laboratories worldwide demand more efficient and scalable workflows, companies are investing in automation, innovation, and strategic collaborations to deliver high-throughput solutions that address the needs of both clinical and research environments.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.65 Billion
Market Size 2030	USD 3.86 Billion
CAGR 2025-2030	6.45%
Fastest Growing Segment	Magnetic-Bead Based Technology
Largest Market	North America

Key Market Drivers

Increased Use of Nucleic Acid Testing in Infectious Disease Management

The expanding use of nucleic acid-based testing for infectious disease management is a primary growth driver in the market. Nucleic acid tests (NATs), including RT-PCR, are now central to disease surveillance and diagnostics due to their sensitivity and accuracy. This shift from traditional diagnostic techniques has increased demand for reliable nucleic acid preparation products. According to data from the Institute for Health Metrics and Evaluation, 85 pathogens were responsible for 704 million disability-adjusted life years (DALYs) in 2019, highlighting the vast global disease burden and the urgent need for precise molecular diagnostics. During the COVID-19 pandemic, the importance of rapid viral RNA extraction was underscored, leading to a global uptick in demand for sample preparation kits and systems. This growing reliance on NATs in public health, hospital labs, and point-of-care settings continues to propel market demand for advanced sample prep technologies.

Key Market Challenges

High Cost of Advanced Sample Preparation Technologies

One of the core challenges in this market is the high cost associated with advanced nucleic acid preparation technologies. Automated systems, next-generation sequencing (NGS) compatible platforms, and specialized consumables can impose significant financial burdens on laboratories. These costs hinder the widespread adoption of such technologies, especially in low- and middle-income countries where healthcare budgets are limited. As a result, many laboratories may opt for manual or lower-cost alternatives, restricting the market's reach and delaying the broader implementation of molecular diagnostics and precision medicine.

Key Market Trends

Integration of Automation and High-Throughput Systems

The integration of automation and high-throughput technologies is a defining trend within the nucleic acid sample preparation market. Automated systems streamline complex workflows, increase throughput, and reduce human error, making them essential in clinical diagnostics and research applications. These platforms, often powered by robotics and AI-driven software, enable laboratories to handle larger volumes of samples efficiently. Automation also enhances reproducibility and consistency in results, which is vital for applications in genomics, infectious disease testing, and precision medicine. As the cost of automation technology becomes more accessible, its adoption is expected to rise significantly across a range of laboratory settings.

Key Market Players

• BGI Group
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Eppendorf SE
• BIONEER CORPORATION
• Endress+Hauser Group Services AG
• Merck KGaA
• Norgen Biotek Corp.
• Aurora Biomed Inc.
• Agilent Technologies, Inc.

Report Scope:

In this report, the Global Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nucleic Acid Sample Preparation Market, By Product:

• Consumables
• Systems
• Accessories & Components

Nucleic Acid Sample Preparation Market, By Technology:

• Spin-Column Based Technology
• Magnetic-Bead Based Technology
• Others

Nucleic Acid Sample Preparation Market, By Therapeutics Area:

• Oncology
• Infectious Disease
• Human Genetics/Population Genetics
• Others

Nucleic Acid Sample Preparation Market, By Application:

• Genomics
• Proteomics
• Others

Nucleic Acid Sample Preparation Market, By End User:

• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Clinical and Diagnostic Laboratories
• Other

Nucleic Acid Sample Preparation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nucleic Acid Sample Preparation Market.

Available Customizations:

Global Nucleic Acid Sample Preparation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Nucleic Acid Sample Preparation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables, Systems, Accessories & Components)
  • 5.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others)
  • 5.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
  • 5.2.4. By Application (Genomics, Proteomics, Others)
  • 5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Nucleic Acid Sample Preparation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Therapeutics Area
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Nucleic Acid Sample Preparation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Therapeutics Area
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Nucleic Acid Sample Preparation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Therapeutics Area
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Nucleic Acid Sample Preparation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Therapeutics Area
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Nucleic Acid Sample Preparation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Therapeutics Area
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Nucleic Acid Sample Preparation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Therapeutics Area
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Nucleic Acid Sample Preparation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Therapeutics Area
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Nucleic Acid Sample Preparation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Therapeutics Area
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. France Nucleic Acid Sample Preparation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Therapeutics Area
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Therapeutics Area
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia-Pacific Nucleic Acid Sample Preparation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Therapeutics Area
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Nucleic Acid Sample Preparation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Therapeutics Area
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Nucleic Acid Sample Preparation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Therapeutics Area
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Nucleic Acid Sample Preparation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Therapeutics Area
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Nucleic Acid Sample Preparation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Therapeutics Area
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Therapeutics Area
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. South America Nucleic Acid Sample Preparation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Therapeutics Area
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Therapeutics Area
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Nucleic Acid Sample Preparation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Therapeutics Area
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Nucleic Acid Sample Preparation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Therapeutics Area
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. Middle East and Africa Nucleic Acid Sample Preparation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Therapeutics Area
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Nucleic Acid Sample Preparation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Therapeutics Area
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Therapeutics Area
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Nucleic Acid Sample Preparation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Therapeutics Area
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Nucleic Acid Sample Preparation Market: SWOT Analysis

14. Competitive Landscape

• 14.1. BGI Group
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. F. Hoffmann-La Roche Ltd
• 14.3. Danaher Corporation
• 14.4. Eppendorf SE
• 14.5. BIONEER CORPORATION
• 14.6. Endress+Hauser Group Services AG
• 14.7. Merck KGaA
• 14.8. Norgen Biotek Corp.
• 14.9. Aurora Biomed Inc.
• 14.10.Agilent Technologies, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer